Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation

Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

Stock-based compensation

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenue

 

$

16

 

 

$

51

 

 

$

46

 

 

$

144

 

Sales and marketing

 

 

9

 

 

 

20

 

 

 

27

 

 

 

51

 

General and administrative

 

 

105

 

 

 

154

 

 

 

261

 

 

 

1,281

 

Research and development

 

 

4

 

 

 

17

 

 

 

4

 

 

 

56

 

Total stock-based compensation

 

$

134

 

 

$

242

 

 

$

338

 

 

$

1,532

 

Schedule of Restricted Stock Unit Activity

A summary of our restricted stock unit activity for the nine months ended September 30, 2025 is set forth below:

 

 

 

Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Outstanding as of December 31, 2024

 

 

38,420

 

 

$

23.01

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

(16,581

)

 

 

23.17

 

Forfeited

 

 

(3,000

)

 

 

14.00

 

Outstanding as of September 30, 2025

 

 

18,839

 

 

$

24.29

 

Schedule of Stock Option Activity

A summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2024

 

 

2,500

 

 

$

56.89

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

Forfeited

 

 

(1,500

)

 

$

38.15

 

 

 

 

 

 

Outstanding as of September 30, 2025

 

 

1,000

 

 

$

85.00

 

 

6.86

 

$

-

 

Exercisable as of September 30, 2025

 

 

1,000

 

 

$

85.00

 

 

6.86

 

$

-

 

 

A summary of our option activity under our 2009 Equity Incentive Plan (the “2009 Plan”) and related information is as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2024

 

 

1,190

 

 

$

91.61

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Forfeited

 

 

(307

)

 

28.48

 

 

 

 

 

 

 

Outstanding as of September 30, 2025

 

 

883

 

 

$

113.56

 

 

 

2.50

 

 

$

-

 

Exercisable as of September 30, 2025

 

 

883

 

 

$

113.56

 

 

 

2.50

 

 

$

-